news

UltraClear: a next-generation technology based on an infrared fiber laser

The UltraClear® (Acclaro) laser is a next-generation technology based on an infrared fiber laser. It delivers visible results on skin quality, while generally being more comfortable and having an easier recovery than traditional ablative lasers. It is intended for patients who want to revive skin radiance, smooth skin texture, correct signs of aging and loss of firmness, treat certain skin imperfections (spots, dilated pores, fine lines and wrinkles, scars, acne scars) and certain superficial skin lesions (nevi, keratoses, etc.).

UltraClear® by Acclaro is a "cold" ablative fiber laser, validated by clinical studies and approved by the FDA (the American health authority). It uses a wavelength of 2910 nm, designed to be strongly absorbed by the water contained in the skin.

This innovative technology allows for highly targeted ablation of skin layers, with less thermal diffusion to surrounding tissue.

The result: generally faster recovery, with fewer side effects, while maintaining excellent effectiveness for resurfacing and dermal stimulation.

Learn more:

> Information sheet: UltraClear Laser

🇬🇧About the translation: Parts of the English version of this website were translated using computer generated translation. If you notice a significant error or if you have any doubt regarding the medical information provided, please send us a message.

Share:
Tags:
news
Dr Cédric Kron - Plastic surgeon in Paris

Former resident, Gold Medal of Surgery and Head of Clinic of Paris Hospitals (APHP), Dr. C. Kron is qualified in Plastic, Cosmetic and Reconstructive Surgery. He practices as a plastic surgeon in Paris, with a comprehensive and tailor-made approach of aesthetic treatments.

Other articles :

Revitalize your skin before summer with the biorevitalizing peel

The biorevitalizing peel is ideal before summer, as it does not require any social downtime or additional sun precautions.

BIA-ALCL risk in patients with breast implants

French plastic surgeons have been concerned about breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) since information was released by the FDA.

Breast implant removal

Dr Cédric Kron places implants that meet European (CE) and American (FDA) standards and are not affected by the issue involving PIP laboratory implants.

3D breast augmentation simulation

Example of a 3D breast augmentation simulation with implants, correlated with the patient's wishes and anatomy, and corresponding to the exact references of the implants that will be used.